Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis

There are no approved diagnostic biomarkers for at-risk non-alcoholic steatohepatitis (NASH), defined by the presence of NASH, high histological activity and fibrosis stage ≥2, which is associated with higher incidence of liver-related events and mortality. FNIH-NIMBLE is a multi-stakeholder project...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanyal, Arun J., Shankar, Sudha S., Yates, Katherine P., Bolognese, James, Daly, Erika, Dehn, Clayton A., Neuschwander-Tetri, Brent, Kowdley, Kris, Vuppalanchi, Raj, Behling, Cynthia, Tonascia, James, Samir, Anthony, Sirlin, Claude, Sherlock, Sarah P., Fowler, Kathryn, Heymann, Helen, Kamphaus, Tania N., Loomba, Rohit, Calle, Roberto A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579051/
https://www.ncbi.nlm.nih.gov/pubmed/37679433
http://dx.doi.org/10.1038/s41591-023-02539-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579051/
https://www.ncbi.nlm.nih.gov/pubmed/37679433
http://dx.doi.org/10.1038/s41591-023-02539-6

Ejemplares similares